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Abstract 
 
Aims: Lack of  CuZnSOD in homozygous knockout mice (Sod1
-/-
) leads to accelerated age-related muscle loss 
and weakness, but specific deletion of CuZnSOD in skeletal muscle(mSod1KO mice) or neurons (nSod1KO 
mice) resulted in only mild muscle functional deficits and failed to recapitulate the loss of mass and function 
observed in Sod1
-/-
 mice. To dissect any underlying cross-talk between motor neurons and skeletal muscle in the 
degeneration in Sod1
-/-
 mice, we characterized neuromuscular changes in the Sod1
-/-
 model compared with  
mSod1KO mice and examined degenerative molecular mechanisms and pathways in peripheral nerve and 
skeletal muscle. Results: In contrast to mSod1KO mice, myofiber atrophy in Sod1
-/-
 mice was associated with 
increased muscle oxidative damage, neuromuscular junction degeneration, denervation,  nerve demyelination 
and upregulation of proteins involved in maintenance of myelin sheaths. Proteomic analyses confirmed 
increased proteasomal activity and adaptive stress responses in muscle of Sod1
-/-
 mice that were absent in 
mSod1KO mice. Peripheral nerve from neither Sod1
-/-
 nor mSod1KO mice showed increased oxidative damage 
or molecular responses to increased oxidation compared with wild type mice. Differential Cysteine labelling 
revealed a specific redox shift in the catalytic Cysteine residue of peroxiredoxin 6 (Cys47) in the peripheral 
nerve from Sod1
-/-
 mice. Innovation and Conclusion: These findings demonstrate that neuromuscular integrity, 
redox mechanisms and pathways are differentially altered in nerve and muscle of Sod1
-/-
 and mSod1KO mice. 
Results support the concept that impaired redox signaling, rather than oxidative damage, in peripheral nerve 
plays a key role in muscle loss in Sod1
-/-
 mice and potentially sarcopenia during aging. 
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Introduction  
Potential mechanisms involved in age–related muscle atrophy and weakness (sarcopenia) have been 
investigated  through examination of homozygous Cu,Zn-superoxide dismutase (CuZnSOD) knockout mice 
(Sod1
-/-
mice) (19,42,53).  At birth these mice are indistinguishable from wild type (WT) mice, but by 5-8 mo of 
age, muscles of the lower limb of Sod1
-/-
 mice display an accelerated neuromuscular aging phenotype associated 
with myofiber atrophy, neurological impairments and functional deficits that progress through adulthood. Many 
features of the Sod1
-/-
 mouse model mimic those observed in 28-30 mo old WT mice (26,42,65) and in older 
humans (26,68) including; increased levels of oxidative damage (19,26,42,53), a constitutive activation of 
redox-sensitive transcription factors (49,66), loss of maximum contractile force (26,42), deterioration of 
neuromuscular junctions (NMJ) (12,19,49), and deficits in mitochondrial function (19). Hence, it has been 
suggested that the Sod1
-/-
 mouse model represents a useful model for the study of chronic oxidative damage in 
the context of neuromuscular aging which may facilitate identification of potential mechanisms and pathways 
that are implicated in sarcopenia in humans (42). 
 
Deciphering the key pathways and mechanisms underlying neuromuscular aging has been difficult due to the 
complex association between loss of motor units and reduction of muscle mass, which are interlinked and occur 
with the advance of age (27). Motor nerves and muscles are well known to have co-ordinated and 
interdependent role in maintaining a healthy neuromuscular system, specifically the viability of motor neurons 
is recognized to be dependent upon continued exposure to neurotrophic factors released by myofibers (18). In 
addition, a number of reports have also revealed that manipulations which alter NMJ integrity may induce a 
phenotype that closely resembles age-related muscle atrophy and weakness (6,23,55).  
 
To elucidate whether the accelerated loss of muscle mass and function observed in the Sod1
-/-
 aging model is 
initiated primarily by alterations in the redox status  proximal  or distal to the neuromuscular junction synapse, 
“conditional knockout models” were generated to determine whether specific CuZnSOD gene deletion targeted 
to skeletal muscle (mSod1KO) (70) or motor neurons (nSod1KO) (57) was sufficient to initiate the sarcopenic 
phenotype seen in Sod1
-/- 
mice. Additionally, a “nerve rescue” mouse model was developed in which human 
SOD1 was specifically expressed in neurons of Sod1
-/-
 mice (49). This model showed no premature loss of 
muscle mass or function suggesting a key role for neuronal redox status in regulation of muscle mass. Together 
these findings suggest that specific deletion of CuZnSOD in either skeletal muscle (70) or motor neurons (57) 
alone is not sufficient to induce neuromuscular degeneration and that deficits in both tissues are essential to 
recapitulate the atrophic phenotype observed during aging in the Sod1
-/-
 model. Moreover, these results indicate 
that there is intricate muscle-nerve cross-talk that is essential for optimal skeletal muscle function. 
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In order to assess the relative role of impaired redox homeostasis in skeletal muscle and neurons in loss of 
skeletal muscle mass, the current study aimed to examine the molecular mechanisms and pathways in pre- and 
post-synaptic tissues of Sod1
-/-
 and mSod1
-/-
 mice using a series of biochemical, physiological and redox 
proteomic techniques. Specifically, to dissect the underlying redox cross-talk between nerve and muscle in this 
process, we employed a proteomic approach including a differential Cys labelling step (35) to identify key 
regulatory redox changes and pathways that are modified in the Sod1
-/-
 model compared with mSod1KO mice. 
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Results  
CuZnSOD removal induces myofiber atrophy and oxidative damage in Sod1
-/-
 but not in mSod1KO mice. 
As previously reported there was no evidence for the expression of CuZnSOD in any of the tissues from Sod1
-/-
 
mice (Fig. 1A). Loss of CuZnSOD protein expression specifically in skeletal muscle of mSod1KO mice was 
confirmed by immunoblotting analysis in soleus (SOL), extensor digitorum longus (EDL), anterior tibialis (AT), 
and gastrocnemius (GTN) muscle lysates (Fig. 1B). No change in CuZnSOD protein content in other tissues 
including; peripheral sciatic nerve (SN), heart, liver, lung, spleen, kidney or brain were observed (Fig. 1B). In 
some occasions, very faint bands depicting low expression of CuZnSOD were observed in skeletal muscle of 
mSod1KO mice (see GTN results, Fig. 1B). To confirm whether this was due to non-myogenic CuZnSOD 
contamination, we examined CuZnSOD protein content (Fig. 1C, middle panel) and enzymatic activity (Fig. 
1C, bottom panel) assessed by native gels, in a muscle fiber preparation devoid of all nonmyogenic cells, using 
isolated flexor digitirum brevis (FDB) muscle fibers (Fig. 1C, top panel). No expression or activity of 
CuZnSOD was observed in FDB lysates of mSod1KO compared to the respective WT mice, confirming specific 
deletion of CuZnSOD in skeletal muscle of the mSod1KO model. Body weight did not change significantly  
between the different mouse genotypes examined in this study, the absolute muscle and tissue masses are 
presented (Tables 1, 2). There was a significant reduction in mass of AT and GTN muscles from Sod1
-/-
 mice 
(42), compared with the respective WT (Sod1
+/+
) littermate controls (Table 1). In contrast to the Sod1
-/-
 model, 
there was no evidence of atrophy in any of the muscles or tissues studied from mSod1KO mice (Table 2). 
Absolute mass of GTN muscle was greater in mSod1KO mice, compared to the respective controls (Table 2). 
To examine the structure of skeletal muscle, histological analysis of the AT muscle/strain was performed (Fig. 
1D, E). A significant number of centrally nucleated fibers were observed in both strains (Fig. 1D, E) indicating 
previous cycles of degeneration and regeneration (53). Average fiber CSA was significantly reduced in Sod1
-/-
 
mice (data not shown in detail) but not in the mSod1KO model, as previously described (53,70). To define 
whether lack of CuZnSOD in Sod1
-/-
 and mSod1KO mice altered fiber type composition, immunolabelling was 
performed for the four isoforms of myosin heavy chains (MHC) on AT cryosections (Fig. 1F). As previously 
reported (52), AT muscle expressed MHC IIA, IIX and IIB fibers but there was no evidence for MHC I 
expression (Fig. 1F) . No change in MHC isoform content was detected between muscles from either genotype 
compared with the respective WT controls (Fig. 1G), implying no significant changes in fiber type composition. 
No overt invasion of muscle by mononuclear (inflammatory) cells was seen on the histology sections from 
either model (Figs 1D, E). 
 
To determine the effect of CuZnSOD ablation, in the mSod1KO and Sod1
-/-
 models, on muscle redox 
homeostasis, a series of biochemical and IHC techniques were performed. In contrast to the mSod1KO model, 
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skeletal muscle from Sod1
-/-
 mice showed increased protein oxidation, lipid peroxidation and DNA damage that 
was apparent as elevated levels of protein carbonyls (Fig. 1H, I), 4-hydroxynonenal protein adducts (4-HNE), 
(Fig. 1J, & Supplementary Fig. S1), malondialdehyde (MDA) content (Supplementary Fig. S2) and an increase 
in the primary enzyme responsible for excision of 7, 8-dihydro-8-oxoguanine lesions, oxoguanine DNA 
glycosylase (OGG1), (Fig. 1K) indicating an increase in oxidative DNA damage in skeletal muscle of the Sod1
-
/-
 model (20). In addition, muscle from Sod1
-/-
 mice showed  an increase in global protein nitration levels, as 
previously described (53), which was not evident in the mSod1KO model compared to the respective WT 
controls (Fig. 1L). Moreover, in contrast to Sod1
-/-
 mice, skeletal muscle of mSod1KO mice did not appear to 
alter mitochondria-mediated apoptotic pathways assessed via changes in cytochrome c cytosolic content and 
cleaved/procaspase-3 levels (Supplementary Figs. S3A-D). Cleaved caspase-3 was significantly elevated in the 
Sod1
-/-
 model (Supplementary Fig. S3A), linked to increased release of mitochondrial cytochrome c and 
Smac/DIABLO pro-apoptotic proteins to the cytosol (Supplementary Fig. S3C). Overall, these data suggest that 
in contrast to the Sod1
-/-
 mice, specific ablation of CuZnSOD in mSod1KO mice does not replicate the 
prominent myofiber atrophy observed in Sod1
-/-
 mice which is associated with gross changes in muscle redox 
homeostasis.  
 
Neuromuscular junction degeneration and sciatic nerve demyelination in Sod1
-/-
 mice is not associated 
with overt changes in oxidative damage in peripheral nerve. Based on previous (70) and current 
observations that deletion of CuZnSOD specifically in to skeletal muscle does not replicate the prominent 
myofiber atrophy that occurs in the Sod1
-/-
 model (Fig. 1 and Tables 1, 2), we hypothesized that retention of 
CuZnSOD expression in neuronal tissue of mSod1KO mice would also preserve motor neuron integrity and 
function. To examine this, confocal immunofluorescence imaging of neuromuscular junctions (NMJ) of the AT 
muscle was performed (Fig. 2A, B). As shown previously (19,49), NMJs from the Sod1
-/-
 model displayed 
marked structural changes as determined by immunohistology (Fig. 2A). Motor axons displayed regions of 
abnormal thinning, distension, and sprouting, and  contrary to the pretzel-like shape of postsynaptic endplates 
from mSod1KO mice (Fig. 2B), endplates of Sod1
-/-
 mice were denervated, dispersed and extensively 
fragmented (Fig. 2A). To determine whether the marked structural NMJ aberrations observed in the Sod1
-/-
 
model were linked to altered peripheral nerve integrity, the contents of myelin-associated proteins involved in 
the formation, maturation and turnover of myelin sheaths were examined. These included myelin basic protein 
(MBP), myelin-associated glycoprotein (MAG), peripheral myelin protein 22 (PMP22), myelin protein zero 
(MPZ), protein gene product 9.5 (PGP9.5), and connexin 32/GJB1 (CX32) which were assessed in sciatic nerve 
(SN) lysates from the Sod1
-/-
 and mSod1KO mouse models (Fig. 2C-E). MBP expression was significantly 
reduced in the Sod1
-/-
 mice (Fig. 2C, E). Moreover, SN from the Sod1
-/-
 model was associated with a 
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compensatory upregulation of CX32 (also known as MYP0) and a trend towards a reduction (p=0.06) in PMP22 
protein levels (Fig. 2C, E). Contrary to SN from Sod1
-/-
, mSod1KO mice showed no evidence of altered content 
in any of the proteins studied (Fig. 2D, E and Supplementary S4, Motor axons from SN cross-sections of the 
Sod1
-/-
 mouse model showed altered morphology and reduced myelin thickness, resulting in a g-ratio gain (axon 
diameter/myelinated fibre diameter), (Supplementary Fig. S4,) also suggesting peripheral nerve demyelination 
occurs in this model.  
 
To determine if the aberrant changes in peripheral nerve/motor neuron integrity displayed in the Sod1
-/-
 mouse 
model was associated with impaired redox homeostasis and elevated oxidative damage (40), we examined 
protein and lipid peroxidation in SN lysates of Sod1
-/-
 and mSod1KO mice (Fig. 2F-I). Neither model showed an 
increase in any of the markers studied (Fig. 2F-I). To confirm the lack and/or expression of CuZnSOD in the 
peripheral nerve of the Sod1
-/-
 and mSod1KO models, superoxide dismutase (SOD) isoforms were quantified 
(Fig. 2J, K). As anticipated CuZnSOD expression was not evident in SN lysates of Sod1
-/-
 mice (Fig. 2J), with 
no changes in MnSOD expression in the peripheral nerve of either models. Taken together, these data 
demonstrate that retention of CuZnSOD expression in motor neurons of the mSod1KO model prevents the 
degenerative alterations in motor neuron/peripheral nerve integrity that occurs in the Sod1
-/-
 genotype, 
highlighting the role of motor neuron integrity in age-associated muscle atrophy, although the prominent 
neuromuscular degeneration seen in Sod1
-/-
 mice was not associated with an increase in overall oxidative 
damage in peripheral nerve. 
 
Global label-free proteomic analysis shows an altered redox proteome in skeletal muscle of Sod1
-/-
 mice. 
The differences in structural and redox changes observed in peripheral nerve and skeletal muscle of Sod1
-/-
 
compared with mSod1KO mouse models prompted examination of the molecular nerve-muscle signaling 
mechanisms and pathways in response to muscle-specific or global loss of CuZnSOD. Global proteomic 
analysis (35,36) of skeletal muscle from each genotype was undertaken and heatmaps representing significantly 
changed proteins and volcano plots highlighting proteins detected of interest are presented in Fig. 3A, B. The 
proteomic analysis (multiscatter plots depicted in Supplementary Fig. S5 A, B; identified proteins and their 
relative quantification are included in Supplementary Files S1, 2) confirmed the loss of CuZnSOD (SODC) 
from skeletal muscle in both the Sod1
-/-
 and mSod1KO mice (Fig. 3A-B, respectively). The label free analysis 
showed a general trend for an upregulation of antioxidant proteins including catalase (CATA), thioredoxin 
(THIO) and peroxiredoxins 3 and 5 (PRDX3 and PRDX5) in skeletal muscle of Sod1
-/-
 mice (Fig. 3A). In 
addition, skeletal muscle of the Sod1
-/-
 strain showed significant increases in mitochondrial metabolic and 
respiratory enzymes involved in energy metabolism including ATP synthase subunits alpha and beta (ATPA 
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and ATPB), NADH dehydrogenase iron-sulfur protein 3 (NDUS3), cytochrome c oxidase subunit 2 (COX2), 
mitochondrial aldehyde dehydrogenase (ALDH2), Delta (3 5) – Delta (2 4) – dieonyl – CoA isomerase (ECH1) 
and the mitochondrial 10 kDa heat shock protein (CH10) (Fig. 3A). Analogous changes were not seen in 
skeletal muscle from the mSod1KO mice although significant increases in carbonic anhydrase 2 and 3 (CA2 and 
CA3) and glycoprotein alpha 1-antitrypsin (A1AT) were observed compared with the respective WT littermate 
controls (Fig. 3B). In addition, mSod1KO mice exhibited a significant reduction in protein disulfide isomerase 
(PDIA4), a protein involved in DNA repair (EMSY), acylphosphatase (ACYP2) and the cytoplasmic glycolytic 
enzymes gamma-enolase (ENO2) and phosphoglucomutase - 1 (PGM1). Overall, these results suggest that 
global loss of CuZnSOD results in an upregulation of proteins involved in both antioxidant protection and 
mitochondrial metabolism as a result of the altered redox homeostasis (Fig 1) and mitochondrial dysfunction 
that have previously been described (19). In contrast, deletion of  CuZnSOD specifically in  skeletal muscle 
does not replicate these findings and had a predominant effect on cytoplasmic metabolism.  
 
Pathway analysis of proteomic data reveals an induction of antioxidant genes in skeletal muscle of Sod1
-/-
 
mice. Pathway analysis of quantitative proteomic data further demonstrated an upregulated antioxidant response 
in skeletal muscle of Sod1
-/-
 (Fig. 4A) with only moderate changes in mSod1KO mice (Fig. 4B). Pathway 
analysis indicated an induction of the main redox regulatory proteins including the mitochondrial superoxide 
scavenging system (MnSOD) and H2O2 scavenging enzymes including CAT, GPX and proteins of the TRX-
PRX system. To confirm these pathways, the protein content of regulatory enzymes for reactive oxygen and 
nitrogen species (RONS) including all six isoforms of peroxiredoxin (PRDX 1-6), (Fig. 4C-E), glutathione 
peroxidase 1 (GPX1) and catalase (CAT), (Fig. 4F, G) were measured. As shown in Fig. 4C-G, ablation of 
CuZnSOD in Sod1
-/-
 and mSod1KO mice induced an upregulation of PRXs and GPX1. Specifically, loss of 
CuZnSOD in skeletal muscle alone, resulted in a significant increase in PRDX 4-6 (Fig. 4D, E) and GPX1 (Fig. 
4G), whereas skeletal muscle from the Sod1
-/-
 model exhibited increased contents of PRDX 2-6 (Fig 4C, E) and 
GPX1 (Fig. 4F). In addition, there was a trend towards increased CAT content (p=0.06) in skeletal muscle of 
the Sod1
-/-
 mice only (Fig. 4F and confirmed by proteomics results). It is noteworthy that compensatory 
upregulation of all RONS regulatory proteins was greater in the Sod1
-/-
 mice compared with the mSod1KO 
model (Fig. 3A, B and 4C-G). Moreover, we have previously reported increased MnSOD protein content in 
skeletal muscle of Sod1
-/-
 (53) but not in mSod1KO mice (70). The NFB signaling pathway is known to partly 
regulate the expression of RONS antioxidant enzymes (47) and previous reports haveindicated that in contrast 
to the mSod1KO model (70), skeletal muscle of  Sod1
-/-
 mice show increased NFB activation (49,66). Together 
these findings suggest that the elevated oxidative damage seen in skeletal muscle of the Sod1
-/-
 aging model is 
associated with a greater adaptive response in the “antioxidant” system compared with the mSod1KO model.  
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Pathway analysis of proteomic data reveals an induction of proteolytic systems in skeletal muscles of 
Sod1
-/-
 mice. Previous findings have shown that proteolytic systems play a crucial role in muscle homeostasis, 
by the degradation of myofibrillar (56) and oxidatively modified proteins (3,15). One of the major pathways 
revealed to be altered by the quantitative proteomics results due to CuZnSOD ablation was the ubiquitin-
proteasome system. Analyses showed an induction of proteolytic systems in skeletal muscle of the Sod1
-/-
 mice 
(Fig. 5A, B), particularly for the 20S proteasome (Fig. 5A). To confirm the pathway analysis data, we measured 
the level of ubiquitin-bound proteins in AT skeletal muscle of Sod1
-/-
 and mSod1KO mice (Fig. 5C, D). 
Ubiquitinated proteins were significantly elevated in skeletal muscle of the Sod1
-/-
 model (Fig. 5C) with no 
apparent changes in muscle of the mSod1KO mice (Fig. 5D). Moreover, elevated ubiquitination was associated 
with increased expression of α subunits and catalytic β1, β2 and β5 constitutive proteasomal subunits in muscle 
of Sod1
-/-
 mice only (Fig 5E, F). Proteasome regulation was further assessed by measuring the ATP-independent 
and ATP-stimulated degradation of the fluorogenic peptide Suc-LLVY-AMC for 20S and 26S proteasomal 
activity, respectively (Fig. 5G). In contrast to muscle of the mSod1KO model, both ATP-independent (top 
panel) and ATP-stimulated activity (bottom panel) of the proteasome was significantly elevated in Sod1
-/-
 mice 
(Fig. 5G). Next to assess the contribution of the calpain/calpastatin myofibrillar proteolytic system (61), protein 
levels of the Ca
2+
-dependent cysteine protease calpain I, and the inhibitor calpastatin (63) were assessed in 
muscle of Sod1
-/-
 (Fig. 5H) and mSod1KO (Fig. 5I) genotypes. Skeletal muscle of Sod1
-/-
 mice exhibited 
reduced levels of calpain I potentially due to elevated expression of the inhibitor calpastatin (Fig. 5H). Muscle-
specific ablation of CuZnSOD did not alter the content of the calpain/calpastatin system (Fig. 5I). In summary, 
these data suggest that in contrast to the mSod1KO mice, the myofiber atrophy and elevated oxidative damage 
to skeletal muscle seen in the Sod1
-/-
 model is coupled to enhanced expression and proteolytic activity of the 
proteasome system.    
 
Label Free Proteomics and Differential Cysteine Labelling of Peripheral Nerve from Sod1
-/-
 and 
mSod1KO mice. Heatmaps of significantly changed proteins and volcano plots of global label free proteomic 
data from the SN of Sod1
-/-
 and mSod1KO mice are presented in Fig 6A, B (Multiscatter plots are depicted in 
Supplementary Fig. S6 A, B; identified proteins and their relative quantification are included in Supplementary 
Files S3, 4). Label free quantitative proteomic data (Fig. 6A, B) supported the reduction in in structural proteins 
MBP and CX32 (MYP0) in Sod1
-/-
 mice shown in Figures 2C-E. Significant changes were also detected in 
redox regulated proteins including PRDX 5 and thioredoxin reductase 1 (TRXR1), but also metabolic enzymes 
known to be redox regulated (14,33,35,62) including transketolase (TKT), isocitrate dehydrogenase (IDH3A), 
electron transport flavoprotein subunit alpha (ETFA) and the cytoskeletal regulator gelsolin (GELS), (Fig. 6A) 
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were down-regulated in SN of the Sod1
-/-
 model. There was an up-regulation of the lipid binding proteins; 
apolipoproteins A1 and A2 in the SN of the Sod1
-/-
 model, which parallels the upregulation of apolipoprotein E 
found in the peripheral nerves of old mice (37). Peripheral nerve of the mSod1KO model showed an up-
regulation of catalase but a down-regulation of glutathione peroxidase 3 (GPX3), (Fig. 6B). A reduced protein 
content of carbonic anhydrase 3 (CAH3) and alpha 1 anti-trypsin (A1AT) were also seen, which contrasts with 
an up-regulation of these proteins in skeletal muscle from this genotype (Fig. 3A, B).  
 
Although our findings indicate no overt oxidative damage in peripheral nerve of the Sod1
-/-
 and mSod1KO 
models, oxidative modification of specific proteins or local temporal alterations in reversible redox 
modifications may not be detected by standard approaches (37,69) and hence, we looked for more subtle 
changes in homeostatic redox regulation of SN tissue in both the Sod1
-/-
 and mSod1KO models by using redox 
proteomic techniques to differentially label reduced and reversibly oxidized Cys residues (34,35). Although 
there were some minor changes to the oxidation state of specific Cys residues in key metabolic proteins, the 
most notable effects were found in the catalytic Cys residues of redox signaling enzymes PRDX 6 (Cys47) and 
5 (Cys95) (Fig. 6C, D respectively). Fig 6C represents the relative proportion of Cys47 of PRDX 6 in the 
reduced (blue bars) and reversibly oxidised (red bars) state. It is clear that there was a significant shift in the 
redox state towards reversible oxidation of this key 1-Cys peroxiredoxin in the peripheral nerves from the Sod1
-
/-
 mice that was not detected in the SN from mSod1KO mice (Fig. 6C, left panel). A representation of the redox 
state of Cys95 of PRDX 5 is also shown in Fig. 6D. In this case, a shift in the redox state towards reversible 
oxidation was observed in peripheral nerves of the mSod1KO model only (Fig. 6D, right panel). It is relevant 
that the increased oxidation  was not universal across all redox active Cys residues detected, with some Cys 
residues showing a greater proportion in the reduced form, nevertheless it identifies key shifts in key regulatory 
redox proteins whether in overall abundance or in the oxidation state of specific Cys residues. 
 
Pathway analysis of proteomic data reveals no overt changes in antioxidant or adaptive signaling 
responses in peripheral nerve of Sod1
-/-
 and mSod1KO mice. In order to assess the molecular nerve signaling 
mechanisms and pathways in response to muscle-specific and global loss of CuZnSOD, pathways analysis of 
quantitative proteomic data from peripheral nerve of Sod1
-/-
 (Fig. 7A) and mSod1KO mice (Fig. 7B) was 
performed. In agreement with the lack of significant changes in protein oxidation and lipid peroxidation (Figs 
2F-I), neither model showed an induction in antioxidant pathways (Fig 7A, B). To confirm the lack of changes 
in adaptive stress signaling responses, we assessed the protein expression of redox regulatory systems 
including; H2O2 scavenging enzymes including cytosolic CAT and mitochondrial PRDX 3 (Fig. 7C, D), 
endothelial nitric oxide synthase (eNOS) isoenzyme (Fig. 7E, F), and heat shock proteins (HSPs), (Fig. 7G-I) all 
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of which have a significant role in the protection against the damaging effects of increased RONS production 
(5,49). Densitometric analysis of the immunoblots presented in Fig. 7C-H showed no significant changes in any 
of the redox regulatory enzymes or protective proteins in SN lysates of Sod1
-/-
 and mSod1KO mice (Fig. 7C-I). 
There were trends toward increased levels of CAT (p=0.09), (Fig. 7D) and a reduction in mitochondrial 
HSP10/CH10 (p=0.06), (Fig. 7H, I) in SN of the mSod1KO transgenic mice compared with the respective WT 
controls. Activation of the NFB pathway was examined in peripheral nerves of Sod1-/- and mSod1KO 
genotypes (Fig. 7J-L). Contrary to increased NFB activation in atrophic muscle of Sod1-/- strain (49,66), 
peripheral nerve showed no significant changes in activation as indicated by phosphorylation of IB-α 
(Phospho IB-α), total IB-α content (a key inhibitor of NFB activation), or NFB-P65 protein content (total 
and phosphorylated), (Fig. 7J, L). Peripheral nerve of the mSod1KO model showed some evidence of enhanced 
activation of NFB signaling pathways by a significant reduction in total IB-α content and a trend towards 
increased Phospho IB-α content (p=0.09), (Fig. 7K, L) which may partly explain the elevated CAT content in 
SN of mSod1KO mice (Fig. 7D). Overall, these data suggest that neuromuscular degeneration in Sod1
-/-
 mice is 
not associated with adaptive stress responses in peripheral nerve but rather specific changes in oxidation state of 
key Cys residues in redox signaling proteins. In addition, muscle-specific ablation of CuZnSOD in the 
mSod1KO model appears to alter NFB signaling pathway in peripheral nerve indicating some redox mediated 
cross-talk between skeletal muscle and motor neurons in the mSod1KO mice. 
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Discussion 
Substantial evidence indicates that age-related loss of skeletal muscle is linked to alterations in the oxidative 
status of redox-responsive proteins (34) and elevated oxidative modifications of macromolecules such as 
proteins, lipids and DNA (47). Although the area remains controversial (46,52), it has been suggested that 
alterations in redox homeostasis play a crucial role in sarcopenia, and we have previously reported that removal 
of CuZnSOD in homozygous knockout mice (Sod1
-/-
) induces accelerated age-related muscle loss and weakness 
(19,42,53). The atrophic phenotype displayed in the Sod1
-/-
 model shares many features of normal aging 
including, a reduction in fiber CSA (19,42) and contractile force (26,42), a constitutive activation of redox-
sensitive transcription factors (49,66), increased levels of oxidative damage (19,26,42,53), neurological 
impairments (12,19,49), and deficits in mitochondrial function (19). We have therefore suggested that the Sod1
-
/-
 mouse model may provide a model to investigate the mechanisms and pathways by which impaired redox 
signaling can contribute to age-related skeletal muscle atrophy and identify potential mechanisms and pathways 
that underlie sarcopenia in humans.  
 
Deciphering the key pathways and mechanisms underlying age-related muscle atrophy and weakness has 
proved to be challenging due to the technical difficulties in unravelling the association between loss of motor 
units and reduced muscle mass that occur with advancing age (27). The symbiotic relationship between motor 
nerves and muscles is essential for the maintenance of a functional neuromuscular system. Several reports that 
have manipulated pathways involved in the maintenance of NMJ integrity and postsynaptic motor endplate 
acetylcholine receptors (AChRs) lead to a phenotype which closely resembles neuromuscular aging (16). These 
studies include enhanced degradation by the overexpression of neurotrypsin (6), depletion of the nerve-derived 
organizer of postsynaptic differentiation agrin (55), and a reduction in the expression of tyrosine kinase receptor 
B (23), a receptor for neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and neurotrophin 4 
and 5. Moreover, evidence has shown that the viability of motor neurons is recognized to be reliant on the 
sustained exposure to neurotrophic factors released by myofibers (18).  
 
To unravel whether the muscle decline and weakness presented in the Sod1
-/-
 micse is initiated by defective 
redox signaling within motor neurons, or skeletal muscle, conditional knockout models including mice with 
specific deletion of CuZnSOD targeted to skeletal muscle (mSod1KO) (70) or motor neurons (nSod1KO) (57) 
were generated together with a “nerve rescue” mouse model in which human SOD1 was specifically expressed 
in neurons of Sod1
-/-
 mice (49). To directly assess the relative roles of impaired redox homeostasis in skeletal 
muscle or motor neurons in the loss of muscle mass and function, the focus of this study was to characterize the 
neuromuscular changes that occur in the Sod1
-/-
 aging model compared to the mSod1KO strain (which show no 
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evidence of muscle loss) and examine the molecular mechanisms and pathways that occur in both peripheral 
nerve and skeletal muscle. Our aim was to examine the cross-talk and relevance of pre- and postsynaptic 
changes in redox homeostasis on the loss of neuromuscular integrity and function that occurs with aging. 
 
We confirmed that mice lacking CuZnOD specifically in muscle maintain muscle mass similar to respective WT 
mice and do not reproduce the accelerated neuromuscular aging phenotype of the constitutive whole-body Sod1
-
/-
 strain, including the multiple biochemical and physiological changes. Ablation of CuZnSOD in skeletal 
muscle of mSod1KO mice induced no overt changes in oxidative damage but these mice showed some evidence 
for a compensatory upregulation in RONS protective enzymes. Myofiber atrophy in muscle of Sod1
-/-
 mice was 
linked to elevated oxidative damage in DNA, proteins and lipids, reflective of adaptations in stress responses to 
oxidants, and an increase in the expression and proteolytic activity of the proteasome system, previously shown 
to contribute to muscle wasting in inherited muscle disorders including myopathies and muscular dystrophies 
(56). It is noteworthy that removal of CuZnSOD in both models resulted in many myofibers of Sod1
-/-
 and 
mSod1KO mice exhibiting centrally located nuclei reflecting previous cycles of degeneration and regeneration 
(Fig. 1). The relatively minor effect seen following tissue-specific removal of CuZnSOD in skeletal muscle of 
mSod1KO mice supports the conclusion that compromised redox signaling within skeletal muscle is not the 
primary factor responsible for initiating loss of muscle mass in the Sod1
-/-
 mice or in age-related sarcopenia. 
Other reports examining  mice with conditional knockout of MnSOD in type IIB skeletal muscle fibers 
(TnIFastCreSod2
fl/fl
) (28) or mice with muscle specific over-expression of rat nNOS (nNOS
Tg
) (43,53) where 
compromised redox homeostasis is predicted have also failed to produce a degenerative muscle phenotype with 
aging.  
 
Consistent with our previous observations (19), the accelerated sarcopenic phenotype observed in Sod1
-/-
 mice 
was accompanied with altered motor neuron integrity. Preterminal motor axons displayed regions of abnormal 
thinning, distension, and sprouting and the postsynaptic endplates were denervated, dispersed and extensively 
fragmented. These findings are in accord with recent reports that showed enhanced mRNA expression of 
AChR-α and an increase in Runx1 and GADD45α transcription factors that potentially reflect up-regulation of 
NMJ components in response to denervation in Sod1
-/-
 mice (49). Other data from the Sod1
-/-
 model have shown 
that the denervation and NMJ fragmentation that occus in the Sod1
-/-
 model is associated with altered 
electrophysiological properties including a reduction in both the amplitude and the frequency of mEPPs, 
indicating altered neurotransmission in skeletal muscle of Sod1
-/-
 mice (49). In the current study, we further 
report that neuromuscular aging in the Sod1
-/-
 model is linked to altered peripheral nerve integrity. Sod1
-/-
 mice 
exhibit sciatic nerve demyelination and a compensatory upregulation of CX32, a neuronal protein involved in 
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the maintenance of myelin sheaths (58). In addition, peripheral nerve of the Sod1
-/-
 model showed diminished 
MBP content and a trend towards reduced levels of PMP22 neuronal protein. PMP22 is known to promote 
myelin development in early stage formation and has a crucial role in regulating myelin thickness and integrity 
(32). It has been reported that mRNA levels of both MBP and PMP22 decrease significantly in the sciatic nerve 
of 22–24 mo old male rats (38,39) and that PMP22 rapidly declines in the degenerating distal stump after 
transection of sciatic nerves in adult rats (4,22). In line with our findings, age-related changes in peripheral 
nerve axonal structure have previously been associated with a reduction in structural proteins and also with an 
increased content of proteins upregulated in brain in neurodegenerative diseases and during aging (11). Overall, 
these observations contribute to understanding of the age-related alterations of the peripheral nervous system 
(PNS) but also help identify the role of redox-dependent proteins in the maintenance of PNS myelin sheath with 
aging.  
 
Previous studies have shown that isolated mitochondria from muscle of Sod1
-/-
 mice exhibit elevated release of 
H2O2 with subsequent deficits in mitochondrial function (19) and early studies reported that transection of the 
motor nerve is coupled to large and sustained increases in muscle mitochondrial RONS release (41), with an 
increased activation of cytosolic phospholipase A2 (cPLA2) in the denervated muscle (1,2). cPLA2 activity 
controls arachidonic acid release from membrane phospholipids, and this fatty acid acts as a substrate for lipid 
metabolic pathways catalyzed by lipoxygenase, cyclooxygenase, and cytochrome P450 (50). It is thus 
reasonable to assume that Sod1
-/-
 associated overt oxidative damage and muscle loss, potentially due to lack of 
appropriate innervation of the muscle, are likely secondary to PNS deficits, since these changes did not occur in 
the mSod1KO model, which express CuZnSOD in motor neurons and which showed no evidence of altered 
peripheral nerve and motor neuron integrity. Further evidence to support  a deficit in muscle innervation in the 
Sod1
-/-
 model  is provided by previous observations that direct stimulation of muscle from Sod1
-/-
 mice elicited a 
consistent increase in maximum isometric force production compared with using nerve stimulation in age-
matched WT littermate controls (26,60), implying that lack of CuZnSOD in PNS of Sod1
-/-
 genotype results in 
denervation of myofibers, and a failure of neuromuscular transmission. Finally, the observation/hypothesis that 
age-related myofiber atrophy is not only due to effects in the muscle, but also related to processes within motor 
neurons that innervate skeletal muscle is supported by work from our group that has shown that neuron-specific 
expression of CuZnSOD in motor neurons of Sod1
-/-
 under control of the synapsin 1 promoter (SynTgSod1
-/-
 
transgenic mice) (49) prevented NMJ degeneration and loss of muscle mass and function that occurs in the 
Sod1
-/-
 mice. Overall these data imply that alterations in redox signaling in motor neurons may play a role in 
initiating sarcopenia in the Sod1
-/-
 strain.  
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The lack of evidence for elevated oxidative damage or adaptive stress/signaling responses in peripheral nerve of 
Sod1
-/-
 mice was unexpected in light of the changes in peripheral nerve integrity seen in the Sod1
-/-
 strain. We 
did not detect any apparent changes in markers of oxidative damage (protein carbonyls, 4-HNE) in peripheral 
nerves from either mouse model used in this study. Although, we previously reported a minor  increase in 
RONS in SN tissue from old mice, protein carbonyl levels were similar between adult and old mice (37). 
Previous studies of the redox active cysteine residues of proteins revealed a minor increase in reversible 
oxidation of specific proteins in SN of old mice compared with adult mice including Cys47 of PRDX 6, Cys95 
of PRDX 5, Cys263 of Neurofilament heavy polypeptide, Cys114 of Annexin A6, Cys49 of Pyruvate kinase 
M1/M2, and Cys254 of Creatine kinase b (37). This pattern of increased oxidation did not occur across all 
redox-active cysteines, with some cysteines showing a greater proportion in the reduced form with aging (37), 
reflecting age-related modifications in redox signaling rather than overt increases in oxidative damage in SN 
tissue. Subtle changes in RONS and the subsequent redox modifications of regulatory proteins can result in 
altered molecular/redox signaling processes and physical function (30,31). Of particular interest from the data 
presented here is the shift towards reversible oxidation in Cys47 of the 1-Cys peroxidase PRDX 6. It has 
previously been demonstrated that the yeast orthologue of this protein utilizes GSH to complete its catalytic 
cycle (45). It is noteworthy that apart from its peroxidase activity, this protein also exhibits phospholipase A2 
activity that is involved in activation of NADPH oxidase 2 (13,67). The catalytic triad responsible for its 
phospholipase activity 
32
S-
140
D-
26
H, is in relatively close proximity to the peroxidatic Cys47 that we have 
detected and it would be interesting to speculate whether a shift in its redox state would affect its phospholipase 
activity in the peripheral nerve of Sod1
-/-
 mice. The atypical 2-Cys peroxiredoxin, PRDX 5, was also found to 
have a shift in the redox state towards reversible oxidation of its catalytic Cys95, in peripheral nerves of both 
Sod1
-/-
 and mSod1KO models although the changes only reached statistical significance in mSod1KO mice. 
PRDX 5 has been reported  in mitochondria, peroxisomes, cytosol and nuclei and appears to reduce H2O2, alkyl 
hydroperoxides and peroxynitrite (21). Understanding how a change in the redox state of the catalytic Cys 
would affect redox signaling processes requires further investigation. 
Proteomic analyses conducted in the present study revealed an altered proteome in peripheral nerve of Sod1
-/-
 
mice, associated with down-regulation of a number of metabolic enzymes which appear to be redox mediated 
(14,33,35,62). Overall the data presented indicate that despite the observed PNS degeneration in Sod1
-/-
 mice, 
peripheral nerve of this model does not exhibit altered redox homeostasis similar to that seen in the skeletal 
muscle that it innervates but an altered proteome and specific changes in key regulatory redox Cys residues. In 
addition, the results from this study and others imply that minor or transient alterations in the 
oxidation/reduction of key cysteines may contribute to defective redox signaling in peripheral nerve with aging. 
Studies reported here have focused on the peripheral nerve, but it is noteworthy that the lack of any gross 
16 
 
changes in oxidative damage in the peripheral nerve of the Sod1
-/-
 model may not directly reflect the redox 
changes that occur in the cell body of the alpha motor neurons. It is possible that oxidative damage and/or 
disrupted redox signaling, in addition to phenotypic changes, may be more evident in the cell body of the alpha 
motor neurons and further studies in this area appear warranted.  
 
Collectively, these findings demonstrate that neuromuscular integrity and redox homeostasis are differentially 
altered in Sod1
-/-
 and mSod1KO mice. CuZnSOD expression in motor neurons (and potentially other cell types) 
of the mSod1KO model prevented the degenerative alterations in peripheral nerve integrity, increased oxidative 
damage, and elevated ubiquitin-proteasome regulation in skeletal muscle that occurs in the Sod1
-/-
 genotype. 
These results support the concept that CuZnSOD gene deletion and altered redox regulation solely in skeletal 
muscle is not sufficient to initiate muscle atrophy and that impaired redox signaling in peripheral nerve rather 
than oxidative damage may be important in muscle loss in the Sod1
-/-
 model and potentially sarcopenia during 
aging.  A key role for the motor neuron is also supported by data from the “nerve rescue” mouse model where 
human SOD1 was specifically expressed in neurons of Sod1
-/-
 mice (49) leading to complete reversal of the 
sarcopenic phenotype seen in Sod1
-/-
 mice. However, the lack of a degenerative muscle  phenotype in 
conditional knockout mice with specific deletion of CuZnSOD targeted to motor neurons (nSod1KO) argues 
against this possibility (57). The current study suggests that impaired redox signaling associated with NMJ 
degeneration, denervation and demyelination occurs in the absence of overt oxidative damage in peripheral 
nerve in the Sod1
-/- 
mice which may lead to the large increase in muscle oxidative damage seen in that model. It 
is relevant that we have also reported no increase in overt oxidative damage in sciatic nerves of aging wild type 
mice (37) although large increases in oxidative damage are also seen in skeletal muscle with aging. Rather more 
subtle changes in the redox Cys status of specific redox regulated proteins were seen in nerves of both Sod1
-/-
 
mice and aging wild type mice which we have argued is reflective of more subtle changes in redox signaling. It 
is currently unknown whether age-related myofiber atrophy and impaired function inherent with aging in 
humans can be attributed to deficits in motor neurons, or whether age-related deficits in skeletal muscle and/or 
other tissues also play a role. Overall, the models examined in this study highlight that defective redox signaling 
in PNS may play a key role in altering peripheral nerve integrity and potentially age-associated muscle atrophy 
and functional deficits. 
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Innovation  
This is the first study to compare the molecular mechanisms and pathways that occur in both skeletal muscles 
and peripheral nerves of Sod1
-/-
 and mSod1KO mice in an effort to examine the relative cross-talk and role of 
pre- and postsynaptic changes in redox homeostasis in loss of neuromuscular integrity and function that occurs 
with aging. This study highlights that impaired redox signaling in peripheral nerve rather than oxidative damage 
appears to play a key role in altering the integrity of peripheral nerves and motor neurons and potentially age-
associated muscle atrophy and functional deficits. These results are potentially clinically significant and have 
widespread implications for the understanding of sarcopenia during aging. 
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Materials and Methods 
Chemicals and Reagents. Unless stated otherwise, all chemicals used in this study were obtained from Sigma 
Chemical Company. 
 
Animals. All mice were generated at the University of Texas Health Science Center at San Antonio 
(UTHSCSA) and the Oklahoma Medical Research Foundation (OMRF). Mice were maintained under specific 
pathogen-free conditions and were shipped to the Biomedical Services Unit, University of Liverpool at ~5 mo 
of age and maintained until they were tested (mean  age 9 ± 1 mo). At both sites, mice were were maintained 
under barrier conditions in microisolator cages on a 12-h dark/light cycle and were fed a CRM (P) rodent diet. 
Mice were euthanized by cervical dislocation, and muscles/tissues were either rapidly removed, weighed, frozen 
in liquid N2, and stored at -80°C, or embedded in Tissue-Tek (VWR) and rapidly frozen in nitrogen-chilled 
isopentane for histological analysis. All procedures were approved by the University of Liverpool Animal 
Welfare and Ethical Review Body. Experiments were conducted in accordance with UK Home Office 
guidelines under the UK Animals (Scientific Procedures) Act 1986. 
 
Generation of constitutive whole-body Sod1-knockout (Sod1
-/-
) mice.  Generation and characterization of the 
Sod1
-/-
  mouse model has been previously described (10,17,42). To confirm the constitutive whole-body Sod1 
deletion, several tissues were dissected and assayed for SOD1 protein expression (see Fig. 1A). 
 
Generation of muscle-specific Sod1-knockout (mSod1KO) mice. Details of the generation of the mSod1KO 
mouse model has been previously reported (70). To confirm the muscle-specific Sod1 deletion, a variety of 
tissues were dissected and assayed for SOD1 protein expression (see Fig. 1B, C) and enzymatic activity (see Fig 
1C).  
 
All measures were undertaken in adult male mice, 9 ± 1 mo of age. Wild-type (WT) mice used in the present 
study were littermate controls for either the mSod1KO or Sod1
-/-
  mouse model.  Both, mSod1KO and Sod1
-/-
  
mice were compared to their respective age-matched WT littermates. 
 
Determination of muscle structure. Cross sections (12 µm) through the mid-belly of the anterior tibialis (AT) 
muscle were obtained by cryosectioning at -20°C and stained with hematoxylin and eosin (see Fig. 1D, E) as 
previously described (53). Cross sections from 3-4 muscles/mouse strain were examined by blinded observers 
to count individual fiber cross-sectional area (CSA). For these analyses  consecutive images acquired from each 
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cryosection at 10x magnification were merged into a single high-resolution image using Adobe photoshop CS6. 
Image J software was used to quantify individual fiber CSA.   
 
Immunohistochemical analysis of MHC expression. Muscle cross sections (10µm thick) were 
immunolabeled for myosin heavy chain (MHC) isoform expression; MHC I, MHC IIA, MHC IIX and MHC IIB 
using as previously described (52), (see Fig 1F).  
 
Immunofluorescent imaging of neuromuscular junction (NMJ) structure. To visualise NMJs, AT muscles 
were fixed in 4% paraformaldehyde (PFA) for 30min at room temperature and washed 2x5min in PBS. AT 
muscles were treated with 1% Triton X-100 in PBS for 1h at low rocking speed, at room temperature. 
Following permeabilization, postsynaptic motor endplate acetylcholine receptors (AChRs) were 
immunolabelled with AlexaFluor 594-conjugated α-bungarotoxin (α-ΒΤΧ, 1:500, Invitrogen) for 45min, 
followed by subsequent overnight staining at 4
o
C with AlexaFluor 488-conjugated neuron-specific class III β-
Tubulin antibody (TUJ1, 1:400, Merck Millipore) in PBS supplemented with 0.2% Triton X-100. Muscles were 
washed for 2x8min in PBS at low rocking speed at room temperature. Immunofluorescence images of the NMJs 
were obtained using an upright confocal microscope (Eclipse Ni-E system, Nikon). Images were captured and 
analyzed with the Nikon NIS-Elements imaging software. Muscles were kept in the dark at all times during 
staining.  
 
Quantitative analysis of myelination. For the quantitative analysis of myelination, 1-2cm segment of sciatic 
nerve (SN) tissue was fixed in 4% PFA for 20min at room temperature, followed by 2x5min washes in PBS and 
overnight incubation in 30% sucrose at 4
o
C. SN tissues were placed in 7.5% (w/v) porcine-derived gelatine 
solution supplemented with 15% (w/v) sucrose and 0.1% (w/v) sodium azide, pre-warmed to 45
o
C and 
incubated at 37
o
C for 3h. Tissues were left to set at room temperature followed by overnight incubation at 4
o
C. 
SN specimens were embedded in Tissue-Tek (VWR) and rapidly frozen in nitrogen-chilled isopentane for 
histological analysis. Transverse cryosections of SN was performed using a cryostat (Leica) and mounted on 
gelatine-coated slides (FD NeuroTechnologies). Images were obtained using a Nikon C1 confocal laser 
scanning microscope under brightfield at 20x and 60x magnification. To assess myelination of peripheral 
nerves, myelin sheath thickness (μm) and the g-ratio which is proportional to fibre size (axon diameter/fiber 
diameter) were calculated using ImageJ software (44,59).  
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Isolation of single mature skeletal muscle fibers. Single muscle fibers were isolated from the flexor digitirum 
brevis (FDB) muscle of mice as previously described (53,54). An example of an isolated single fiber from the 
FDB muscle is shown in Fig 1C.  
 
Protein Extraction for Redox Proteomics. To identify any global redox changes, a differential Cysteine (Cys) 
labelling protocol was included as reported in our recent publication (35). Briefly muscle and SN samples were 
homogenised directly in 50mM ammonium bicarbonate containing 25mM N-ethylmaleimide (d(0) NEM) pH 8. 
Protein lysates were prepared by centrifugation at 15,000g for 10min at 4°C. Excess d(0) NEM was removed 
using Zeba desalting columns (Thermo Scientific).. 100µg of protein extract was diluted to 160µl with 25mM 
ammonium bicarbonate and denatured by the addition of 10µl of 1% RapiGest (Waters, Manchester, UK) in 25 
mM ammonium bicarbonate and incubated at 80°C for 10min with shaking. 10µl of a 100mM solution of 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was added to reduce reversibly oxidised Cys residues 
followed by incubation at 60°C for 10min. Newly reduced Cys were then alkylated by addition of d(5) NEM 
and incubated at room temperature for 30min. An aliquot of the samples was used at this point to check 
procedure by SDS PAGE. Proteolytic digestion was performed by incubation with Trypsin overnight at 37°C. 
Digestion was terminated and RapiGest removed by acidification (3µl of TFA and incubated at 37°C for 45min) 
and centrifugation (15,000g for 15min). 
 
LC−MS/MS and Label-Free MS Quantification. Samples were analysed using an Ultimate 3000 RSLC nano 
system (Thermo Scientific) coupled to a QExactive mass spectrometer (Thermo Scientific). 2µl of sample was 
diluted in 18 µl buffer (97% H2O, 3% MeCN and 0.1 % formic acid v/v) and 5µl corresponding to 250ng of 
protein was loaded onto the trapping column (PepMap 100, C18, 75µm x 20mm) using partial loop injection for 
7min at a flow rate of 4µL/min with 0.1% (v/v) TFA. Sample was resolved on the analytical column (Easy-
Spray C18 75µm x 400mm, 2µm column) using gradient of 97% A (0.1% formic acid) and 3% B (99.9% ACN 
and 0.1% formic acid) to 60% A and 40% B over 120min at a flow rate of 300nL/min. Data dependent 
acquisition consisted of a 70,000 resolution full-scan MS scan (AGC set to 10
6
 ions with a maximum fill time of 
250ms) and the 10 most abundant peaks were selected for MS/MS using a 17,000 resolution scan (AGC set to 5 
x 10
4
 ions with a maximum fill time of 250ms) with an ion selection window of 3m/z and normalized collision 
energy of 30. Repeated selection of peptides for MS/MS was avoided by a 30sec dynamic exclusion window. 
 
Raw spectra were converted to mascot generic files (MGF) using Proteome Discoverer software (Thermo) and 
resulting MGF files were searched against the UniProt mouse sequence database using an in house Mascot 
server (Matrix Science, London, UK). Search parameters used were: peptide mass tolerance 10ppm; fragment 
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mass tolerance 0.01Da, 1+, 2+, 3= ions; missed cleavages 1; instrument types ESI-TRAP. Variable 
modifications included in search were: d(0) NEM, d(5) NEM, mon-, di-, trioxidation of Cys residues and 
oxidation of methionine with a False Discovery Rate of < 1%. Label-free relative quantification was performed 
using PEAKS7 software (Bioinformatics Solutions Inc., Waterloo, Canada). Label free quantification data was 
imported into Perseus (64) software for generation of multiscatter plots and heatmaps. Heatmaps represent 
proteins that significantly change between genotypes using a -10log P value >20 (equivalent to a p value < 
0.01). Supporting information containing the multiscatter plots (Supplementary Figs. S5, S6) and identified 
proteins and their relative quantification (Supplementary Files S1-4) are shown in supplementary data. 
Differential labelling of Cys residues allowed a targeted analysis of specific Cys residues identified as labelled 
with both d(0) NEM and d(5) NEM using Skyline (29) where m/z, retention times and fragmentation spectra 
allowed the estimation of the d(0) /d(5) NEM or reduced:reversibly oxidized ratio for redox Cys residues from 
the individual parent ion intensities. Data visualization of label free proteomic data using Volcano plots (max 
fold change ≤ 20) was performed using label free quantification data in R studio. Pathway analysis of label free 
quantitative proteomic data was performed using PathVisio (25) together with WikiPathways (24) to visualize 
and highlight altered pathways from detected proteins. 
 
Enzymatic activity assays. Enzymatic activity of CuZnSOD was assessed in native gels, with negative staining 
(see Fig. 1C), as described previously (49,51,70). Briefly, single muscle fibers isolated from the FDB muscle 
were homogenized in 20mM Tris buffer (pH 7.4 at 4°C) supplemented with 0.05% Triton X-100 and protease 
inhibitors. After centrifugation at 14,000rpm for 10min at 4°C, protein of the supernatant was quantified using 
the BCA method following standard protocol (8). Equal amount of protein (20μg) was separated on 10% native 
gel (Criterion Tris HCL pre-cast gel, Bio-Rad) in cold room (4°C) at 150V for 4h. The gel was soaked in a 
solution that contained nitro blue tetrazolium (NBT), riboflavin, and tetramethylethylenediamine (TEMED). In 
this process TEMED reduces riboflavin, which then reduces O2, thereby forming superoxide and the superoxide 
reduces NBT, which forms the characteristic colour of a blue formazan. Regions of SOD activity in the gel are 
colourless since SOD prevents the reduction of NBT. The gel image was recorded with a digital camera-imager 
system (Bio-Rad) and analyzed using Quantity One Software (Bio-Rad) to quantify the intensity of the regions 
representing CuZnSOD activity.  
 
Proteasomal activity was quantified fluorometrically as previously described (7,48). Skeletal muscle 
homogenates were lysed by three freeze–thaw cycles in ice-cold lysis buffer containing (in mM) 250 sacharose, 
25 hepes, 10 MgCl2-6H2O, 1 EDTA (pH 7.8 at 4°C), supplemented with 1.6 dithiothreitol (DTT). Lysates were 
centrifuged at 13,400rpm for 10 min at 4°C to remove nonlysed cells, membranes, and nuclei. Supernatants 
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were incubated in proteolysis assay buffer (in mM) 225 Tris, 6 MgOAc-4H2O, 7.5 MgCl2-6H2O, 45 KCl (pH 
8.2 at 4°C), supplemented with 1.6 DTT. The fluorogenic peptide succinyl-LLVY-methylcoumarin (Suc-
LLVY-AMC) (200μM ) was used as substrate to measure chymotrypsin-like activity of the proteasome. After 
40min of incubation at 37°C, release of methyl coumarin was measured using a microplate fluorometer 
(FLUOstar Optima, BMG) at excitation/emission wavelengths of 360/460nm and activity calculated using free 
methyl coumarin as standards. To exclude other protease activities and ensure the specificity of the assay, the 
selective proteasome inhibitor lactacystin (20μM final concentration) was added to the reaction, and 
proteasomal activity was calculated as the difference between the total activity and that remaining in the 
presence of lactacystin and normalised to the protein concentration of each sample. For assessment of ATP-
stimulated proteolysis (26S proteasome), ATP was added to 5mM final concentration. 
 
Immunoblotting and sub-cellular fractionation. Homogenates were prepared using RIPA buffer containing 
(in mM) 50 Tris (pH 7.4 at 4°C), 150 NaCl and protease inhibitors. Equal amounts of protein (20−50μg) were 
separated by SDS-PAGE and transferred onto nitrocellulose membranes (53). Membranes were stained with 
Ponceau S to ensure equivalent protein loading and transfer.Relative protein abundance was analyzed 
densitometrically and standardized using GAPDH or Ponceau S staining. Membranes were probed using the 
primary antibodies listed in Supplementary Table S1. An ECL kit was used to monitor peroxidase activity 
(Amersham International), and band intensities were analysed using Quantity One Software (Bio-Rad). 
Mitochondrial and cytosolic fractions were obtained from skeletal muscle as previously described (9). 
 
Measurement of protein carbonyls, 3-nitrotyrosine (3-NT), 4-hydroxynonenal (4-HNE) protein adducts 
and malondialdehyde (MDA) content. 3-NT and 4-HNE were analyzed by immunohistochemical and 
immunoblotting. Cryosections (10μm) from AT muscle were immunolabeled for 3-NT and 4-HNE, and staining 
intensity measured by confocal laser scanning microscopy. Protein carbonyls, 3-NT and MDA content in 
muscle lysates containing 20μg protein were assessed with the OxiSelect protein carbonyl, nitrotyrosine and 
MDA Immunoblot kits (Cell Biolabs), respectively. Intensities of 2,4-dinitrophenyl (DNP)-modified proteins 
following derivatization, 3-NT, 4-HNE protein adducts and MDA content were quantified by densitometry.  
 
Statistical Analyses. Data are presented as mean ± SEM for each experiment. Statistical analyses for 
differences between groups were determined using analysis of variance (ANOVA) followed by the post hoc 
LSD test. Single comparisons between two experimental conditions were made using an unpaired Student’s t 
test. Data were analysed using SPSS 22 with p values of less than 0.05 being considered statistically significant.  
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GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GPX1, glutathione peroxidase 1; H2O2, hydrogen 
peroxide; HSP, heat shock protein; IHC, immunohistochemical; MAG, myelin-associated glycoprotein; MBP, 
myelin basic protein; MDA, malondialdehyde; MEM, minimum essential medium eagle; MGF, mascot generic 
files; MHC, myosin heavy chain; MPZ, myelin protein zero; mSod1KO mice, mice with specific CuZnSOD 
gene deletion targeted to skeletal muscle; NBT, nitro blue tetrazolium; NEM, N-ethylmaleimide; nNOS
Tg
 mice, 
mice with muscle specific over-expression of rat nNOS; nSod1KO mice, mice with specific CuZnSOD gene 
deletion targeted to motor neurons; NFB, nuclear factor kappa B; NMJ, neuromuscular junction; OGG1, 
oxoguanine DNA glycosylase; PBS, Phosphate Buffered Saline; PFA, paraformaldehyde; PGP9.5, protein gene 
product 9.5; PMP22, peripheral myelin protein 22; PRX, peroxiredoxin; RONS, reactive oxygen and nitrogen 
species; SN, sciatic nerve; Sod1
-/-
 mice, CuZnSOD homozygous knockout mice; SOD, superoxide dismutase; 
Suc-LLVY-AMC, succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin; SynTgSod1
-/-
 transgenic mice, mice 
with neuron-specific expression of CuZnSOD in motor neurons of the Sod1
-/-
 model under control of the 
synapsin 1 promoter; TCEP, Tris(2-carboxyethyl)phosphine hydrochloride; TEMED, 
tetramethylethylenediamine; TnIFastCreSod2
fl/fl
 mice, mice with conditional knockout of MnSOD targeted to 
type IIB skeletal muscle fibers; TUJ1, neuron-specific class III β-Tubulin antibody; WGA, wheat germ 
agglutinin; WT, wild type. 
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Table 1. Comparison of tissue weights from Sod1
-/-
 and WT (Sod1
+/+
) mice.  
Tissue                  WT (Sod1
+/+
)          Sod1
-/-
               
BW (gr) 32 ± 1.2 30.7 ± 1.4   
AT (mg) 50.1 ± 1.7 41.7 ± 1.1*    
EDL (mg) 11.4 ± 0.8               11.9 ± 0.7    
GTN (mg) 172.5 ± 4.6 120.7 ± 7.6*    
SOL (mg) 9.6 ± 1.2 10.6 ± 0.4    
Liver (gr) 1.77 ± 0.1 1.85 ± 0.2    
Spleen (mg) 119.4 ± 22.6 173.4 ± 27.3    
Kidney (mg) 238 ± 26.6 276.5 ± 39.7    
Heart (mg) 177.7 ± 7.8 190.9 ± 32.7    
Lung (mg) 179.7 ± 26.1 215.3 ± 35.3    
Brain (mg) 440 ± 33 445.3 ± 38.4    
Values are presented as mean ± SEM; *P<0.05 compared with values from WT mice, n=6 mice/group.  
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Table 2. Comparison of tissue weights from mSod1KO and WT mice.  
Tissue                  WT                          mSod1KO                   
BW (gr) 36.1 ± 3 36.9 ± 2.1     
AT (mg) 53.3 ± 1.8 53.7 ± 1.5    
EDL (mg) 10.9 ± 0.6 11.4 ± 0.6    
GTN (mg) 181.7 ± 7.3 206 ± 8.2*    
SOL (mg) 8.3 ± 0.5 9.8 ± 0.5    
Liver (gr) 1.91 ± 0.2 1.76 ± 0.1    
Spleen (mg) 88.1 ± 7.7 79.3 ± 5    
Kidney (mg) 262.1 ± 35.9 242.4 ± 19.8    
Heart (mg) 190 ± 17.3 194.5 ± 21.1    
Lung (mg) 196 ± 16 164.1 ± 10.4    
Brain (mg) 454.4 ± 7.9 435.8 ± 12.6    
Values are presented as mean ± SEM; *P<0.05 compared with values from WT mice, n=6 mice/group.  
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Figure Legends 
Figure 1. Characterization of muscle morphology and redox homeostasis in skeletal muscle of Sod1
-/-
 and 
mSod1KO mice. A) Representative western blots showing CuZnSOD protein content in various tissues of Sod1
-
/-
 and the respective WT mice. B) Representative western blots depicting CuZnSOD protein expression in 
various tissues of mSod1KO and the respective WT mice. C) Confocal image of a single isolated fiber from the 
FDB muscle of a WT (Sod1
+/+
) mouse under bright field. 20x original magnification. Scale bar, 60μm. (top 
panel); Protein expression of CuZnSOD and MnSOD in lysates from single isolated FDB fibers of mSod1KO 
and the respective WT mice (middle panel); Native gel stained for SOD1 enzyme activity in lysates from single 
isolated FDB fibers of mSod1KO and the respective WT mice (bottom panel). D, E) Example of hematoxylin 
and eosin stained transverse sections of the AT muscle from Sod1
-/-
 (D), mSod1KO (E) and the respective WT 
littermate controls. White asterisks depict myofibers with central nuclei. 20x original magnification. Scale bar, 
70μm. F) Representative triple immunofluorescent staining of myosin heavy chain (MHC) isoforms; MHC IIA 
(green), MHC IIX (blue) and MHC IIB (red) performed on an AT cryosection obtained from a mSod1KO 
mouse. Right panel shows enlarged area marked by red box in the left panel to show the selective MHC isoform 
immunolabeling. Scale bar, 500μm. G) Histograms showing the fiber-type distribution of AT muscle from 
Sod1
-/-
 (top panel), mSod1KO (bottom panel) and the respective WT mice. n=3-4 mice/strain. H, I) Western blot 
analysis (top panel) and quantification (bottom panel) of protein carbonyls in AT lysates of Sod1
-/-
 (H), 
mSod1KO (I) and the respective WT mice. *P<0.05 compared with values from the respective WT mice. J) 
Transverse section of an AT muscle from a Sod1
-/-
 mouse immune-labeled for 4-hydroxynonenal (4-HNE, 
green) protein adducts, WGA (5μg/ml, red), to visualize extracellular matrix, and a merged image as indicated 
and analyzed by confocal microscopy. Scale bar, 40μm; 4-HNE content in AT skeletal muscle of Sod1-/-, 
mSod1KO and the respective WT mice (bottom right panel). *P<0.05 compared with values from the respective 
WT mice, n=3 mice/strain. K) Oxoguanine DNA glycosylase (OGG1) protein levels in AT skeletal muscle of 
Sod1
-/-
 (top left panel), mSod1KO (bottom left panel) and the respective WT mice, and densitometric 
quantification of the blots (right panel). *P<0.05 compared with values from the respective WT mice. L) 
Transverse section of an AT muscle from a Sod1
-/-
 mouse immune-labeled for 3-nitrotyrosine (3-NT, purple) 
content, WGA (5μg/ml, green), to visualize extracellular matrix, and a merged image as indicated and analyzed 
by confocal microscopy. Scale bar, 40μm; 3-NT content in AT skeletal muscle of Sod1-/-, mSod1KO and the 
respective WT mice (bottom right panel). *P<0.05 compared with values from the respective WT mice, n=3 
mice/strain.  
 
Figure 2. Peripheral nerve redox homeostasis and neuromuscular junction structure in Sod1
-/-
 and 
mSod1KO mice. A, B) Confocal immunofluorescence imaging of neuromuscular junctions (NMJ) of an AT 
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muscle from a Sod1
-/-
 (A) and mSod1KO (B) mouse. Presynaptic motor neurons immunolabeled with neuronal 
class III β-tubulin monoclonal antibody (TUJ1), a neuronal marker (green), and postsynaptic motor endplate 
acetylcholine receptors (AChRs) stained with AlexaFluor 594-conjugated α-bungarotoxin (red). Small panels 
show enlarged area marked by a box in the larger panel. 10x original magnification (larger panel). Scale bar, 
150μm. C, D) Western blots of myelin-associated proteins including myelin basic protein (MBP), myelin-
associated glycoprotein (MAG), peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ), protein 
gene product 9.5 (PGP9.5), and connexin 32/GJB1 (CX32) in SN lysates of Sod1
-/-
 (C), mSod1KO (D) and the 
respective WT mice. E) Densitometric analysis of the western blots shown in figures (C & D). *P<0.05 
compared with values from the respective WT mice. F, G) Western blot analysis (top panel) and quantification 
(bottom panel) of protein carbonyls in SN lysates of Sod1
-/-
 (F), mSod1KO (G) and the respective WT mice. H, 
I) Western blot analysis (top panel) and quantification (bottom panel) of 4-HNE protein adducts in SN lysates of 
Sod1
-/-
 (H), mSod1KO (I) and the respective WT mice. J, K) Protein expression (top panel) of the main cytosolic 
and mitochondrial superoxide reducing enzymes including; SOD1 and SOD2 in SN lysates of Sod1
-/-
 (J), 
mSod1KO (K) and the respective WT mice; Densitometric analysis of the blots (bottom panel).  
 
Figure 3. Global label-free proteomics of skeletal muscle from Sod1
-/-
 and mSod1KO mice. A, B) Heatmaps 
of significantly up- and downregulated proteins in skeletal muscle of Sod1
-/-
 (A), mSod1KO (B) and the 
respective WT mice detected by PEAKS label-free quantification software (Significance -10log P > 20 or P < 
0.01 and fold change ≥ 2) (top panel); Volcano plots of label free proteomic data showing changes in protein 
content between skeletal muscle of Sod1
-/-
 (A), mSod1KO (B) compared to the respective WT mice (bottom 
panel). Proteins involved in redox regulation are highlighted in red, proteins involved in protein folding and 
stress response are highlighted in blue, and proteins involved in metabolism are in yellow. Proteins highlighted 
are alpha-1-antitrypsin 1-5 (A1AT5), acylphosphatase-2 (ACYP2), mitochondrial aldehyde dehydrogenase 
(ALDH2), ATP synthase subunits alpha and beta (ATPA and ATPB), carbonic anhydrase 2 and 3 (CAH2 and 
CAH3), catalase (CATA), heat shock protein 10 mitochondrial (CH10), cytochrome c oxidase subunit 2 
(COX2), alpha-crystallin B chain (CRYAB), delta (3 5) – delta (2 4) – dieonyl – CoA isomerase (ECH1), 
protein EMSY (EMSY), gamma enolase (ENOG), glutathione peroxidase 1 (GPX1), pyruvate kinase isozymes 
M1/M2 (KPYM), NADH dehydrogenase iron-sulfur protein 3 (NDUS3), protein disulfide isomerase (PDIA4), 
peroxiredoxins 2, 3, 5 and 6 (PRDX2, PRDX3, PRDX5 and PRDX6), phosphoglucomutase 1 (PGM1), 
CuZnSOD (SODC) and thioredoxin (THIO). 
 
Figure 4. Pathway analysis of antioxidant mechanisms in skeletal muscle of Sod1
-/-
 and mSod1KO mice. A, 
B) Regulation of antioxidant proteins (as represented by Pathvisio and WikiPathways) in skeletal muscle of 
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Sod1
-/-
 (A) and mSod1KO mice (B). C, D) Western blots of protein content of the peroxiredoxin (PRX) 
isoforms (PRX I-VI) in AT lysates of Sod1
-/-
 (C), mSod1KO (D) and the respective WT mice. E) Densitometric 
analysis of the western blots shown in figures C and D. *P<0.05 compared with values from the respective WT 
mice. F, G) Western blots for glutathione peroxidase 1 (GPX1) and catalase (CAT) protein levels (top panel) in 
AT skeletal muscle of Sod1
-/-
 (F), mSod1KO (G), and the respective WT mice, and densitometric quantification 
of the blots (bottom panel). *P<0.05 compared with values from the respective WT mice. 
 
Figure 5. Pathway analysis reveal proteasomal activation in skeletal muscle of Sod1
-/-
 but not in mSod1KO 
mice. A, B) Pathways analysis of proteasomal regulation (as represented by Pathvisio and WikiPathways) in 
skeletal muscle of Sod1
-/-
 (A) and mSod1KO mice (B). C, D) Western blots (top panel) and quantification 
(bottom panel) of ubiquitin-bound proteins in AT skeletal muscle of Sod1
-/-
 (C), mSod1KO (D) and the 
respective WT mice. *P<0.05 compared with values from the respective WT mice. E, F) Western blot analysis 
(top panel) and quantification (bottom panel) of α, β1, β2 and β5 proteasomal subunits in AT lysates of Sod1-/- 
(E), mSod1KO (F) and the respective WT mice. *P<0.05 compared with values from the respective WT mice. G) 
Proteasomal activity assessed by ATP-independent (20S proteasome, top panel) and the difference between 
ATP-independent and ATP-stimulated (26S proteasome, bottom panel) lactacystine sensitive degradation of the 
fluorogenic peptide suc-LLVY-AMC in AT lysates of Sod1
-/-
, mSod1KO, and the respective WT littermate 
controls. *P<0.05 compared with values from the respective WT mice, n=4 mice/strain. H, I) Proteolytic calpain 
I and calpastatin protein levels (left panel) in AT skeletal muscle of Sod1
-/-
 (H), mSod1KO (I) and the respective 
WT mice, and densitometric quantification of the blots (right panel). *P<0.05 compared with values from the 
respective WT mice. 
 
Figure 6. Global label-free proteomics and differential Cysteine labelling in peripheral nerve of Sod1
-/-
 
and mSod1KO mice. A, B) Heatmaps of significantly up- and downregulated proteins in SN of Sod1
-/-
 (A), 
mSod1KO (B) and the respective WT mice detected by PEAKS label-free quantification software (p < 0.01 and 
at least one unique peptide) (top panel); Volcano plots of label free proteomic data showing changes in protein 
content between peripheral nerve of Sod1
-/-
 (A), mSod1KO (B) compared to the respective WT mice (bottom 
panel). Proteins involved in redox regulation are highlighted in red, myelin associated proteins are highlighted 
in blue, and metabolic proteins are highlighted in yellow. Proteins highlighted are alpha-1 anti-trypsin (A1AT), 
apolipoprotein A-I and A-II (APOA1 and APOA2), carbonic anhydrase 3 (CAH3), catalase (CATA), heat 
shock protein 10 mitochondrial (CH10), electron transport flavoprotein subunit alpha (ETFA), gelsolin (GELS),  
glutathione peroxidase 3 (GPX3),  isocitrate dehydrogenase [NAD] alpha mitochondrial (IDH3A), myelin basic 
protein (MBP), myelin proteolipid protein (MYPR), myelin protein P0 (MPZ), protein DJ-1 (PARK7) 
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peroxiredoxins 3 and 5 (PRDX3 and PRDX5), CuZnSOD (SODC), extracellular superoxide dismutase (SODE), 
sphingosine 1-phosphate receptor 4 (S1PR4), thioredoxin reductase 1 (TRXR1) and transketolase (TKT). C, D) 
Redox state of Cys47 from PRDX 6 (C) and Cys95 from PRDX 5 (D) in peripheral nerve of Sod1
-/-
 (left panel), 
mSod1KO (right panel) and their respective controls. Blue bars represent the reduced state of the Cys residue 
and red bars the reversibly oxidation of the Cys residue. *Indicates a significant shift (P<0.05) in the redox state 
towards reversible oxidation compared with values from the respective WT mice. 
 
Figure 7. Pathway analysis of antioxidant mechanisms in peripheral nerve of Sod1
-/-
 and mSod1KO mice. 
A, B) Regulation of antioxidant proteins in pathways in peripheral nerve of Sod1
-/-
 (A) and mSod1KO mice (B). 
C, D) Western blots (top panel) of the main cytosolic and mitochondrial H2O2 reducing enzymes including; 
catalase (CAT) and peroxiredoxin III (PRXIII) in SN lysates of Sod1
-/-
 (C), mSod1KO (D) and the respective 
WT mice; Densitometric analysis of the blots (bottom panel). E, F) Protein expression (top panel) of endothelial 
nitric oxide synthase (eNOS) isoform in SN lysates of Sod1
-/-
 (E), mSod1KO (F) and the respective WT mice; 
Densitometric analysis of the blots (bottom panel). G, H) Protein expression of heat shock proteins (HSPs) 
including; mitochondrial HSP10, HSP25, HSP60 and HSC70 in SN lysates of Sod1
-/-
 (G), mSod1KO (H) and the 
respective WT mice. I) Densitometric analysis of the western blots shown in Figures (G & H). J, K) Western 
blots for total and phosphorylated IκB-α (Phospho IκB-α) and P65 content (total and phosphorylated), in SN 
lysates of Sod1
-/-
 (J), mSod1KO (K) and the respective WT mice. L) Densitometric analysis of the western blots 
shown in Fig. 9J, K. *P<0.05 compared with values from the respective WT mice. 
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Supplementary Figures 
 
Supplementary Figure S1. Immunoblots (top panel) and quantification (bottom panel) of 4-HNE protein adducts in AT 
lysates of Sod1
-/-
 (left panel), mSod1KO (right panel) and the respective WT mice. *P<0.05 compared with values from the 
respective WT mice.  
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Supplementary Figure S2. Western blot analysis (top panel) and quantification (bottom panel) of malondialdehyde 
(MDA) content in AT lysates of Sod1
-/-
 (left panel), mSod1KO (right panel) and the respective WT mice. Positive control 
(PC) included bovine serum albumin conjugated MDA (MDA-BSA, 10ng).  
 
Supplementary Figure S3. A, B) Western blot analysis (top panel) and quantification (bottom panel) of procaspase-3 and 
cleaved caspase-3 in AT lysates of Sod1
-/-
 (A), mSod1KO (B) and the respective WT mice. *P<0.05 compared with values 
from the respective WT mice. C, D) Western blots of isolated cytosolic fractions from Sod1
-/-
 (C), mSod1KO (D) and the 
respective WT mice, immunodetected for cytochrome c (Cyt C) and Smac/DIABLO mitochondrial pro-apoptotic proteins 
(middle panel), and densitometric quantification of the blots (bottom panel). The intensity of the bands shown in the 
Ponceau S-stained gel (top panel) was used as a loading control. E) Example western blot of voltage-dependent anion 
channel 3 (VDAC3) and GAPDH content to illustrate the purity of the extracted mitochondrial (Mito) and cytosolic 
(Cyto) skeletal muscle fractions. *P<0.05 compared with values from the respective WT mice. 
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Supplementary Figure S4. A) Myelin blots with their respective loading controls. B) Transverse section of a sciatic 
nerve (SN) from a WT (Sod1
+/+
) mouse (top panel). 20x original magnification. Scale bar, 100μm; Bottom left panel 
shows enlarged area marked by red box in the top panel to show the morphology and myelin thickness of motor axons of 
the peripheral nerve. 60x original magnification. Scale bar, 10μm; Transverse section of a SN from a Sod1-/- mouse 
(bottom right panel). Note reduced myelin thickness of motor axons from peripheral nerve of the Sod1
-/-
 model, indicated 
by arrowheads. 60x original magnification. Scale bar, 10μm; Myelin thickness and g-ratio quantifications (right panel) of 
peripheral nerve from Sod1
-/-
 and the respective WT mice, *P<0.05 compared with values from the respective WT mice, 
n=3 mice/strain. B)  
A) 
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B) 
 
 
Label Free LC-MS Analysis 
MS Data Analysis and Search Parameters 
Result Filtration Parameters. 
Retention Time   ≥ 0 
Retention Time   ≤ 110 
Feature Fold Change  ≥ 1 
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Quality    ≥ 1 
Average Area   ≥ 0 
Charge    ≥ 1 
Charge     ≤ 10 
Confident Sample Number ≥ 1 
With Peptide ID  True 
Normalization   Total Ion current 
Protein Significance   ≥ 20 
Confident Unique Supports ≥ 1 
 
 
Supplementary Figure S5. A, B) Multiscatter plots using the label free quantification data to estimate degree of 
correlation between the different samples of skeletal muscle from Sod1
-/-
 (A), mSod1KO (B) and the respective WT mice. 
R
2
 correlation values are included for each comparison. 
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Supplementary Figure S6. A, B) Multiscatter plots using the label free quantification data to estimate degree of 
correlation between the different samples of sciatic nerve from Sod1
-/-
 (A), mSod1KO (B) and the respective WT mice. R
2
 
correlation values are included for each comparison. 
 
 
 
 
 
Supplementary Files 
Supplementary File S1. LC–MS data for label free quantification data of proteins identified from skeletal muscle 
samples of Sod1
-/-
 vs WT mice. 
Supplementary File S2. LC–MS data for label free quantification data of proteins identified from skeletal muscle 
samples of mSod1KO  vs WT mice. 
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Supplementary File S3. LC–MS data for label free quantification data of proteins identified from sciatic nerves of Sod1-/- 
vs WT mice. 
Supplementary File S4. LC–MS data for label free quantification data of proteins identified from sciatic nerves of 
mSod1KO vs WT mice. 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Tables 
Supplementary Table S1. List of antibodies used for western blotting. 
 
Primary 
Antibody 
Manufacture
r 
Dilutio
n 
Primary Antibody Manufacture
r 
Dilutio
n 
3-NT Cell Biolabs 1:2000 P-IκB-α Abcam 1:1000 
4-HNE Abcam 1:2000 P-P65 Abcam 1:1000 
Calpain I Abcam 1:1000 P65 Abcam 1:1000 
Calpastatin Abcam 1:1000 PGP9.5 Abcam 1:1000 
Casp-3 
(pro/cleaved) 
Abcam 1:1000 PMP22 Abcam 1:1000 
CAT Abcam 1:5000 PRXI Abcam 1:500 
CX32 Abcam 1:1000 PRXII Abcam 1:500 
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Cyt C Abcam 1:1000
0 
PRXIII Abcam 1:2000 
eNOS Abcam 1:1000 PRXIV Abcam 1:1000 
GAPDH Abcam 1:3000
0 
PRXV Abcam 1:1000 
GPX1 Abcam 1:1000 PRXV Abcam 1:1000 
HSC70 Cell Signaling 1:1000 PRXVI Abcam 1:1000 
HSP10 Abcam 1:5000 Smac/DIABLO BD 1:1000 
HSP25 Cell Signaling 1:2500 SOD1 Cell Signaling 1:2000 
HSP60 Cell Signaling 1:5000 SOD2 Cell Signaling 1:2000 
IκB-α Abcam 1:1000 Ubiquitin Abcam 1:2000 
MAG Abcam 1:1000 VDAC3 ThermoFisher 1:1000 
MBP Abcam 1:1000 α-proteasomal 
subunits 
Abcam 1:2000 
MDA Cell Biolabs 1:2000 β1- proteasomal 
subunit 
Santa Cruz 1:1000 
MPZ Abcam 1:1000 β2- proteasomal 
subunit 
Enzo 1:1000 
OGG1 Abcam 1:1000 β5- proteasomal 
subunit 
Abnova 1:1000 
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